LifeScience Alley Programs & Events

21st Annual Alley Institute Scholarship Golf Tournament

Sat, 01 Jan 2000 08:00:00 GMT

For two decades, the Scholarship Golf Tournament has provided a terrific opportunity for team building, networking, and fund-raising. Join us this year for a fabulous day of golf in support of a good cause on one of the premier private courses in Minnesota! This year's tournament will be held at the Golden Valley Golf & Country Club. The tournament sponsorships raise funds for students pursuing careers in the life sciences.

Tournament is a scramble format so players of all abilities are encouraged to participate! Driving range opens at 9:30 a.m. Tournament begins with a shotgun start at 11:30 a.m. (lunch served on the course). The day concludes with dinner, awards and plenty of networking.

Alley Institute is committed to provide actionable solutions to help increase the awareness of career options in the life sciences, and to help ease the work force shortage in these specialized fields. Raising funds through the Scholarship Golf Tournament is a tangible way to make a difference in this effort.

Playing in the Tournament
Players may sign up individually or in foursomes.
Download player registration form.

Thank you to our sponsors:
Medpoint, LLC, Lommen, Abdo, Cole, King & Stageberg, P.A., Pace Analytical Life Sciences, Patterson Thuente, Adolfson & Peterson Construction, Kluge Design Inc., Quality Tech Services, Inc. (QTS), Avicenna Technology, Inc., Scales Advertising, The BioBusiness Alliance of Minnesota, and Chopper College.

Interested in sponsoring?
Sponsorships range from $500 - $5,000, and are a tax-deductible contribution.
View Sponsorship Packages.
Download Sponsorship Reservation Form.

Questions? Call Michelle Holker at (952) 746-3822 or email mholker@lifesciencealley.org

FDA Establishment Registration and Listing: Live Demonstration by FDA Expert

Sat, 01 Jan 2000 08:00:00 GMT

The ''FDA Unified Registration and Listing System'' (FURLS) is the on-line tool that companies must use to complete the annual Establishment Registration and Medical Device Listings for their firm. The FURLS system introduced in October 2007 proved to be a challenge to use in the early days but has evolved over the years and there are some new updates that will improve the process.

With the registration window between October 1 and December 31 of each year, this program is timed to get you the information you need to quickly and efficiently complete the process. If you are involved in managing FDA information and/or directly registering your company and products you should not miss this chance to hear directly from an FDA expert on the FURLS program and how to register all of your facilities and product listings. This program will feature a ''Live on-line Demonstration'' by FDA on how to use the fee payment process and FURLS and DRLM (Device Registration and Listing Module) systems.

This is a key part of your companies compliance program and profile within the FDA system so getting it right is critical to how FDA views and manages your companies pre and post market activities. This program will include the ''how to steps'' and ''practical tips'' to use in successfully completing your Establishment Registration AND Medical Device Listings using the FURLS systems.

Sustainable Manufacturing Solutions for the Medical Manufacturing Industry

Sat, 01 Jan 2000 08:00:00 GMT

Join us for two important topics impacting the medical manufacturing industry: electronic medical device history records and the EU's REACH and RoHS Regulations.

Improving Manufacturing Sustainability through Electronic Records: A Case Study

Automated Control Concepts, Inc. will be presenting a case study of how a Medical Manufacturing company was able to implement an Electronic Device History Record solution and saw significant improvements in the areas of workflow enforcement, data retention and quality, achieving real-time visibility and sustainable manufacturing. Automated Control Concepts, Inc. and Rockwell Automation will address questions at the end of the presentation.

No Data, No Market: The EU's REACH and RoHS Regulation's Impact on the US Medical Device Market in 2010 and beyond.

Foresite Systems will review the history of Product Environmental Compliance beginning with the EU Packaging directives, and walk you through its evolution up to today's multitude of Regulatory Obligations including REACH, RoHS, WEEE, and Battery Directives. Although RoHS is currently out of scope for Medical Device companies, the October 2010 RoHS ReCast vote could drastically change that as well affect CE Marks and FDA approvals.

A Company can be Compliant and still be out of Compliance. Just like 21CFR Part 11, exhibiting evidence of sound process and proper due diligence is a critical component of adherence to these regulations.

REACH Regulations affects all companies, and Carbon Management is a fast-growing concern in terms of Procurement Standards, Public Relations and SEC requirements. These topics and more will be discussed in an interactive nature.

Target Audience:
• Senior Management
• Quality and Regulatory
• General Counsel
• Research and Development
• Design and Product Development
• Information Technology
• Anyone affected by an interruption in their Supply Chain

Alley Chats at Minnetronix

Sun, 01 Aug 2010 07:00:00 GMT

Join your fellow LifeScience Alley members for an evening of high impact networking hosted by Minnetronix.

Alley Chats is a members' only networking and resource building event. There will be a brief welcome address provided by our host and sponsors with the remainder the time devoted to networking. Dress is business casual. Event price of $25 includes complimentary hors d'oeuvres.

Many thanks to our host, Minnetronix, and our sponsors RJ Ahmann Company and Global Medical Instrumentation, Inc. (GMI) for making Alley Chats possible.

Design of Experiments (DOE)

Sat, 01 Jan 2000 08:00:00 GMT

This is a two-day seminar for technical people from R&D, manufacturing, quality, engineering, supplier management, and regulatory affairs departments.

Screening Experiments
Product and process development requires the identification of key factors that control product and process performance. Screening experiments efficiently identify key factors and interactions; provide a way to optimize product and process designs, and to troubleshoot manufacturing. They help shorten development cycle time and reduce cost.
1. Why design experiments?
2. Factorial designs
3. Key success factors
4. Fractional factorial and Plackett-Burman designs
5. Applications using software

Optimization Experiments
DOE approach to product and process design is a two step approach: screening followed by optimization. When effects are not linear, optimization experiments are necessary to optimize product and process designs. Both formulation and process optimization are considered.
1. Sequential assembly of designs
2. Central composite and Box-Behnken designs
3. Mixture designs
4. Model building and response surface optimization
5. Applications using software

Robust Design Method
Robust designs result in small variability. Robust design method, developed by Dr. Taguchi, provides tools to make product and process designs robust against the impact of noise factors. The key to robustness and ways to design and analyze the necessary experiments are considered.
1. Basic principle to achieve robustness
2. Control and noise factor experiments
3. Signal to noise ratio and other analyses
4. System simplification
5. Applications using software

FDA Update on Unique Device Identifier (UDI) Program

Sat, 01 Jan 2000 08:00:00 GMT

The Food and Drug Administration Amendments Act of 2007 was signed into law and includes language related to the establishment of a Unique Device Identification System. This new system when implemented will require:

• creation of a unique identifier for medical devices
• the unique identifier to be placed on the device package label, the device, or both in human readable and/or AutoID formats
• the unique identifier to include production identifiers where applicable, i.e., Lot, Serial Number, Expiration Date
• registration of the unique identifier and associated product attributes in UDI database

The U.S. Food and Drug Administration (FDA) is getting closer to publishing proposed regulation for Unique Device Identification (UDI). The UDI regulation could have a significant impact on the medical device industry, creating standardized identification of medical devices. FDA is currently completing the proposed regulation to implement the UDI program and is expected to publish the proposed rule in 2010.

Attend this program and hear directly from the FDA on how this initiative is advancing, and also get an Industry perspective on how to prepare for implementation of the UDI system.

PROGRAM-AT-A-GLANCE
• History of device identification
• Benefits of a UDI system
• What to expect from the Proposed Rule on UDI
• The Global Harmonization Task Force (GHTF) Ad Hoc Work Group on UDI
• How to establish a UDI system
• FDA's UDI database pilot program
• Adoption and implementation of UDI
• Global Medical Device Nomenclature (GMDN) use with UDI
• HL7 Structure Product Labeling (SPL)
• Industry perspective on UDI implementation

GMO's: The Opportunities, Obstacles and Outlook

Sat, 01 Jan 2000 08:00:00 GMT

GMO's, genetically modified organisms, have been a major player in the marketplace for over a decade in the case of grain crops. Transgenic bacteria and animals are also being used commercially. Significant benefits to producers and consumers can be enumerated. Yet, many questions remain about labeling, testing, regulatory approval and long term health and environmental impacts. The panelists will address the science behind GMO's, discuss future products and markets, and address the policy and public acceptance issues that affect biotechnology-derived foods, feeds and fiber.

Marketing Medical Products in India

Sat, 01 Jan 2000 08:00:00 GMT

When most Americans think of India, they think of low-cost labor and extreme poverty. What most Americans forget is that there is a growing economy in India and a huge middle class (90 million people). This represents a significant opportunity for medical product and service companies in the US. In addition, there are no language barriers, fewer regulation hurdles compared to other countries, and patients pay in cash.

The Minnesota Trade Office has released the following information about India:
• The Indian medical equipment market is estimated to be over $2.3 billion and expected to reach $5 billion by 2012
• It is projected that over 1 million hospital beds will be added by 2012, requiring a total investment of $77.9 billion dollars
• Medical tourism in India was estimated at $350 million in 2006 with potential to grow to 42 billion by 2012

Join us for a robust discussion about the opportunities to increase revenue for your company in India. Tushar Gupta, Founder of Sanguine International, will speak about his experiences bringing American medical products into India. We have also invited John Dinusson, CEO and President of Orthocor Medical, to speak about his experiences with the Indian market.

Learner outcomes:
• Understand how the medical market is segmented in India
• Learn more about cost of doing business - everything from round-trip costs (including product registration), shipping costs, and distributor commissions
• Selling through distributors
• The pros and cons of moving some functions to India
• Learn the most effective marketing strategies
• Understand cultural idiosyncrasies that can impact business success
• Better understand global trends that can align with your company's goals
• Utilize the National Export Initiative financing

This seminar is designed for anyone responsible for product or service expansion. We look forward to seeing you on the 23rd.

Medical devices and MR compatibility: What to Test and How to Test

Sat, 01 Jan 2000 08:00:00 GMT

The talk will cover basic MR physics and technology and its interaction with medical devices. Medical device manufacturers will find this information useful for defining product design and better understanding FDA criteria for MR compatibility.

Supporting and Managing Investigator-Initiated Research

Sat, 01 Jan 2000 08:00:00 GMT

Why should a medical device company invest in investigator-initiated studies? This discussion will focus on unique opportunities and challenges of investigator-initiated programs specific to the medical device industry. An overview on how to successfully develop and implement an investigator-initiated research program will be presented.

By the end of this presentation, attendees will be able to understand the value of supporting investigator-initiated research to expand innovation and discovery. Attendees will also understand the framework required to execute a successful investigator-initiated research program. Lastly, attendees will understand how a field-based scientist organization can improve the quality, impact and outcomes from investigator-initiated research.

Topics
• Key elements required to manage investigator-initiated research
• Policies and Procedures
• Review process
• Execution and follow-Up
• Proving value
• Using field-based Medical Scientist to enhance and manage investigator-initiated research
• Exploring the role of field-based scientist and the impact on improving success for investigator-initiated research
• Outline various models where field-based scientists support clinical research
• Demonstrate the value that they bring to investigator-initiated research
• Outline responsibilities in supporting Investigator-Initiated Trials (IITs)
• Provide examples of different obstacles to success and strategies for overcoming them
• Identify core competencies that aid in the ability of the field-based scientist to support IITs
• Measuring the impact of field-based scientist with responsibilities in IITs

Developing New Products and Services in a Reform Environment

Sat, 01 Jan 2000 08:00:00 GMT

On August 23rd, LSA sponsored a conference on the impact of the new healthcare reform act. Almost 200 people packed the DoubleTree Ballroom to hear Senator Klobuchar and leaders of healthcare networks talk about the challenge of dealing with 32 million new patients entering the system at a time when state and federal deficits are skyrocketing.

What new products and services will this new reality demand? Many companies flourished when DRGs were introduced while others perished. The same can be said when Group Purchasing Organizations and Integrated Delivery Networks came on the scene. And once again, reform is upon us. Will your company thrive in this new reality? Will you survive?

Given this new shift in healthcare delivery, we have asked Rod Greder and Gary Jader to develop a healthcare specific New Product and Service course, which is an adaptation of their popular New Products Management class they taught at the University of St. Thomas for the past seven years. We have also asked Tom Hughes, an attorney and healthcare reform expert, to set the context for this four half day workshop in October.

This interactive course has been designed for anyone involved in new product or service development: engineers, scientists, new product marketers, researchers, project team leaders, and product managers. It will introduce best practices, tools, processes, terminology, as well as team and company culture tips and techniques for optimizing new product and service development.

There has never been a better time for you to be thinking about What's Next? in your pipeline of new offerings. We have built this new class around four half days in October, which will minimize your time away from work and also give you an opportunity to apply new learnings after each class.

Participant Outcomes:
• Develop an integrated view of product development and management in a new reform environment.
• Understand and manage the complexity of a NPD project from start to finish.
• Learn best practices for generating and screening ideas and idea management.
• Learn about portfolio planning and business metrics for measuring NPD.
• Learn how to create and manage a systematized innovation process.
• Learn about Design for Six Sigma, Lean NPD, Concurrency and Stage-Gate approaches.
• Learn voice of the custome methodologies to identify customers & their needs.
• Learn how successful companies ensure new product success.
• Glean insights from the diverse perspectives of your peers in other markets.
• Prepare for the PDMA NPDP Certification Exam.

Business Outcomes:
• Improved success rates, reduced cycle times, and NPD projects that stay within budget and on schedule.
• Enhanced morale and productivity of cross-functional NPD teams.
• Improved competencies of developers/managers with access to expanded NPD toolkits.

Material to be covered:
• Foundations of New Product Development in a new reform environment
• Opportunity Analysis & Voice of Customer
• Discovery and Screening of Ideas and Concepts
• Development and Testing Protocols
• Successful Launch of New Products and Services
• Post Launch Management
• OD, HR and Cross-functional Team Aspects of NPD
• NPD Planning, Process Improvement & Metrics - Automation, databases and supporting methodologies (DFSS, Lean, QFD, VSM, Stage-Gate, Concurrency)
• Creativity, Innovation & Breakthrough Thinking
• Project Management and New Product Development

Completion of this program provides attendees with the knowledge needed to pass the New Product Development Professional Certification (NPDP) exam through the Product Development & Management Association and gain national certification.

Please note that this workshop extends multiple days - October 1, 8, 15 and 29.

Statistics for Managers

Sat, 01 Jan 2000 08:00:00 GMT

Statistics for Managers is a one-day seminar geared toward technical managers in industry - supervisors, managers, directors, vice presidents and other technical leaders - from research and development, manufacturing, quality, engineering, supplier management, and regulatory affairs departments.

To guide effective implementation of statistical methods, managers need to know what the key statistical tools accomplish, their pros and cons, when to use which tool, and what questions to ask to promote the timely and effective use of statistics. This seminar communicates the key concepts of practically useful statistical methods and how they apply to the various stages of R&D and manufacturing - research, product design, process design, validation, manufacturing and continuous improvement.

The purpose of this seminar is to provide practical guidance on how to effectively guide and implement statistical methods, by answering questions such as:

1. Why not to use a t-test and what to replace it with?
2. Size matters - how much data to collect?
3. Why design experiments - is it not going to cost too much and take too long?
4. What is the key to designing robust products and processes?
5. Setting specifications - arbitrary or is there a method to it?
6. What must you know to properly design process validation studies?
7. One minute process management - how to use an at-a-glance-display?
8. Is my measurement system acceptable - and how to improve it?

Reimbursement Realities - The Untold Story

Sat, 01 Jan 2000 08:00:00 GMT

CMS and private payor reimbursement - especially in an era of heightened Comparative Effectiveness Research - is a critical determinant of a bioscience company's success or failure. Even when all the critical milestones are met, including CMS approval - it's not a ''done deal'' until payors reimburse. Hear insights and experiences from seasoned entrepreneurs and advisors who will share the lay of the land and discuss hidden pitfalls in reaching these endpoints. CEOs will have an opportunity to network with other life science industry leaders in this protected ''by invitation only'' meeting. [Note: This program is exclusively for entrepreneurs heading emerging core life science companies.]

For questions regarding eligibility please contact Dana Boyle at 952-746-3820 or dboyle@lifesciencealley.org.

Thank you to our Small Business Leaders' Forum sponsors:
Faegre & Benson, Dymedex Consulting, and Argenta Reimbursement Advisors, and BioBusiness Alliance of Minnesota.

Diabetes Leadership Roundtable

Sat, 01 Jan 2000 08:00:00 GMT

The inaugural meeting of LifeScience Alley's Diabetes Leadership Roundtable will feature executives with the national American Diabetes Association, who will update our health care community on the latest issues and trends in scientific research and approaches to patient care for Type 1 & Type 2 Diabetes as well as prevention. They will also share their main push for advocacy at the federal level. In addition to gaining an up-to-date understanding of the association's top initiatives and engaging with other leaders at the intersection of our health care and life science community, you'll hear how Minnesota's exceptional health industry can respond to the ADA's call to action.

The LifeScience Alley Diabetes Leadership Roundtable meets quarterly to continue connecting key players and supporting new developments in the field of diabetes. Thank you to our Lead Founding Sponsor: Dorsey & Whitney LLP

Women's Leadership Roundtable

Sat, 01 Jan 2000 08:00:00 GMT

Our community is fortunate to include many talented leaders and executives from diverse backgrounds who share both a passion for the life sciences and health care fields, as well as the drive to make a difference. LifeScience Alley is launching its fourth Women's Leadership Roundtable for Life Science & Health Care Professionals to help you engage outside of your organization, diversify your experiences, broaden your go-to network and develop your leadership skills. This program is designed specifically for women executives in the life science and health care community - medical device, pharmaceutical and biotechnology firms as well as health care providers and payers. It has been called by past participants one the most efficient and ''on-point'' ways to enhance your leadership skills.

As a member of a high-functioning peer group, you connect on a regular basis to:
• Discuss workplace challenges and develop solutions with leaders who share your experiences
• Explore industry trends and influences with other executives who have unique vantage points
• Enhance your leadership skills, outlook and career path

Our commitment:
• Confidentiality in an enjoyable and non-competitive setting
• Professionally facilitated and focused discussions each month
• One-one-one coaching opportunities with Dr. Polach or Dr. Byrd

Your commitment:
• Meet once each month for 3 hours with your roundtable group
• For nine months--$3,800 (may be made in two payments)

Your results:
• A network of peers invested in your success
• Tangible ideas of strategies and tactics for growing and expanding your business
• Competitive industry intelligence, as you share experiences in the life science & health care fields
• A larger, more diverse and more integrated ''circle of impact'' (referral network in the community)
• Improved leadership skills under the guidance of our experienced professional facilitators

Logistics
The roundtable group will be made up of leaders from non-competing organizations throughout our community - with a focus on life sciences and health care. Monthly meetings will be hosted by roundtable members and facilitated by Leadership Solutions, Inc. On October 8th, the ''Women's Leadership Roundtable for LifeSciences and Healthcare Professionals'' will launch - including several members of the 2009/2010 roundtable. If you are interested in this program, please contact Dana Boyle, Vice President of Business Development at LifeScience Alley by phone at 952-746-3820 or by e-mail at dboyle@lifesciencealley.org or fill out and send in this REGISTRATION FORM.

Science & Technology Gubernatorial Debate

Sat, 01 Jan 2000 08:00:00 GMT

LifeScience Alley, The Minnesota High Tech Association, MN Nano and The BioBusiness Alliance of Minnesota present a debate by the three major party candidates for Governor. Topics addressed will cover how Minnesota's next Governor can best support the growth and development of science & technology enterprise in Minnesota.

Thank you to our sponsor: Hysitron Inc.

Discussions on Upcoming SBIR & STTR Funding Opportunities, the Bridge Award, and Tips for Applying

Sat, 01 Jan 2000 08:00:00 GMT

Learn about how your company may be eligible to tap into the financial resources and new funding opportunities available from the National Cancer Institute's (NCI) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs.

Deepa Narayanan from the NCI SBIR Development Center will provide in-depth information about funding opportunities available to small businesses to support the research, development, and commercialization of technologies and products designed to prevent, diagnose, and treat cancer. This program will feature practical advice on strategies for developing successful NCI SBIR & STTR funding proposals. New contract funding opportunities for about $11M in a range of novel technology areas to help successfully finance and lead innovations to commercialization will be discussed.

The NCI SBIR Program solicits proposals for SBIR contracts once annually. As compared to grant funding opportunities, SBIR contract topics are focused in scope and require the completion of specific activities and deliverables. In order to catalyze targeted technology development in key need areas that will result in a commercial product, the NCI SBIR Program is moving more of its resources towards contracts. The SBIR and STTR Programs offer funding in nanotechnology, anti-cancer agents, imaging agents, novel digital x-ray sources, image guided interventions and medical imaging software and many more areas of interest to the NCI.

In addition, the session will highlight the new SBIR Phase II Bridge Award, which provides up to $3 million funding to advance a promising therapeutic or device toward commercialization.

Also learn about new programs that NCI has launched to support its SBIR companies in moving their technologies towards the marketplace. These include the NCI SBIR Investor Forum to be held November 9th, 2010 at Stanford University. NCI will also describe its new SBIR Regulatory Assistance Program in development.

Meet the Experts - Deepa Narayanan will be available for one-on-one discussions to answer specific questions regarding SBIR/STTR funding opportunities immediately after the presentation (rsvp to Sharon Hollister shollister@lifesciencealley.org / 952-746-3813 to reserve a time slot).

Benefits of applying for NCI SBIR & STTR funding opportunities:
• SBIR & STTR awards provide recognition, verification, and visibility
• SBIR & STTR funding can be a leveraging tool to help attract additional funding from other third-party investors
• Awards are not loans; no repayment is required
• SBIR & STTR funding is non-dilutive capital (i.e., an award does not impact the company's stock or shares in any way). Intellectual property rights to technologies developed under these programs are retained by the small business concern.

For more information about this NCI SBIR & STTR, please visit http://sbir.cancer.gov. For a listing of all funding opportunities from the NCI SBIR & STTR Programs, please visit: http://sbir.cancer.gov/funding/receipt_dates.asp.

The National Cancer Institute Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are government set-aside programs that seek to increase small business participation and private-sector commercialization of technology developed through federal research and development.

Effective Project Leaders = Successful Projects

Sat, 01 Jan 2000 08:00:00 GMT

There are many challenges to leading a successful project. The overarching issue, however, comes down to your ability to lead others. It's more critical to learn how to manage upward, downward and side to side than ever before. That's exactly what you'll learn in this training workshop. It's not about working harder. Instead it's about honing your ability to learn and lead. Then it's about creating the conditions so that others enjoy success all around you.

Project leadership skills and tools are the focus of the class rather than pure project management or administration tools. The class is highly interactive, providing everyone the opportunity to both learn from and share their experiences and knowledge. At the end of each topic, the class identifies key points that can be taken away from the class and productively used tomorrow!

Focus Areas
• Define the project
• Create the Credible Schedule
• Manage Scope Creep
• Communications is the Currency of Leadership
• Build and Manage Team
• Anticipate and Manage - Risk and Opportunity
• Execute to Plan
• Close the Project

The target participant for this workshop include moderate to experienced project leaders and mangers from manufacturing, logistics, marketing, product development, quality assurance, IT, finance, and other domains. This is a great chance for project leaders to interact with peers from other domains and better understand shared issues and challenges.

''PLS's Project leadership class focused on the critical balance between people, tasks, communication and personal accountability. In one day, it highlighted many of the key learnings I have experienced over 25 years of leading projects. Appropriate for experienced senior project leaders, entry level project leaders and senior management. A great class to use as to kick off a large project.''
- IT ERP Business Integration Project Leader, Fortune 500 Food Company

''I found the Project Leadership class led by PLS to be extremely helpful in developing my skills in program management. Unlike other courses I've taken, the PLS class focuses on actionable skills rather than abstract theory. Those skills are reinforced with group work on case studies throughout the class. The group left energized and ready to go apply new knowledge back on their various projects.''
- Sr. Product Development Manager, St. Jude Medical

For those participants that are PMI certified, this course is accepted for 8 hrs of PDU credit.

Fees will be waived for the 4th participant from the same company. Please contact Lauren Steffel lsteffel@lifesciencealley.org to enroll the 4th attendee or to inquire about additional registrants.

Course materials will be sent by PLS instructors prior to the start of the workshop. Project Leadership Services, Inc. (PLS) provides consulting services focused on project leadership, mentoring, temporary management, and business process re-engineering. Visit their website.

Diabetes Leadership Roundtable

Sat, 01 Jan 2000 08:00:00 GMT

Please join our Diabetes Leadership Roundtable that will meet quarterly to continue connecting key players and supporting new developments in the field of diabetes. (More detailed description coming soon)

Thank you to our Lead Founding Sponsor: Dorsey & Whitney LLP

A View from the Captain's Chair - CEO All-Star Panel

Sat, 01 Jan 2000 08:00:00 GMT

Seasoned medtech/biotech CEO's share their insights on surviving and thriving in this market for the benefit of their peers and the next-generation life science company leaders. This annual session is a chance for them to reflect on their achievements and offer advice that they've learned along the way. Minnesota's vibrant life science culture is well-respected, even in such hotbeds as Silicon Valley. The Small Business Leaders' Forum speaks to the well-connected, ''willing to give back to others'' community that exists here. As always this program will provide time to network with other life science industry leaders in a protected ''by invitation only'' setting. [Note: This program is exclusively for entrepreneurs heading emerging core life science companies.]

For questions regarding eligibility please contact Dana Boyle at 952-746-3820 or dboyle@lifesciencealley.org.

Thank you to our Small Business Leaders' Forum sponsors:
Faegre & Benson, Dymedex Consulting, and Argenta Reimbursement Advisors, and BioBusiness Alliance of Minnesota.